LncRNA NamePTCSC3
Variant TypeSNP
Variant IDrs944289
Specieshuman
Circulating
Survival
CeRNA
Methylation
Enhancer
Drug
Disease/Traitpapillary thyroid carcinoma
LncRNA Target GeneNA
Tissuetyroid tissue, (TPC-1, BCPAP, COS-7, 293T) cell lines
Experimentreal-time PCR, northern blot, luciferase reporter assay, microarray
Function DescriptionThe SNP rs944289 was located in a binding site for the CCAAT/enhancer binding proteins (C/EBP). The risk allele destroyed the binding site in silico. Both C/EBP and C/EBP activated the PTCSC3 promoter in reporter assays (P = 0.0009 and P = 0.0014, respectively) and the risk allele reduced the activation compared with the nonrisk allele (C) (P = 0.026 and P = 0.048, respectively). Restoration of PTCSC3 expression in PTC cell line cells (TPC-1 and BCPAP) inhibited cell growth (P = 0.002 and P = 0.019, respectively) and affected the expression of genes involved in DNA replication, recombination and repair, cellular movement, tumor morphology, and cell death. Our data suggest that SNP rs944289 predisposes to PTC through a previously uncharacterized, long intergenic noncoding RNA gene (PTCSC3) that has the characteristics of a tumor sUp regulationpressor.
Pubmed ID22586128
Year2012
TitleThe polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor sUp regulationpressor type
External Links
Links For PTCSC3GeneCards HGNC NONCODE LncRNAWiki lncrnadb
Links For papillary thyroid carcinomaOMIM Cosmic
Links For rs944289 dbSNP ClinVar OMIM